Across TCGA pan-cancer cohorts, RNA5SP239 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNA5SP239 data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RNA5SP239 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP239 expression acts as an unfavorable survival marker, although some lineages such as CESC show a favorable association.
LUAD, KIRC, and BRCA are the cancer types where RNA5SP239 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.